Paradigm Health · Series B

AI research platform making clinical trials part of routine patient care

Amount

$78M

Round

Series B

Valuation

—

Announced

Dec 2025

Investors

Lead investor

ARCH Venture Partners

Participating investors

General Catalyst

GV (Google Ventures)

Lux Capital DFJ Growth F-Prime Mubadala Capital American Cancer Society BrightEdge Fund

Notes

funding refresh

Other Paradigm Health rounds

Date	Round	Amount
—	Series A	$203M	Details →
—	Series B	$78M	Details →